Advertisement

Index by Author

February 1993; 42 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abrahamian, H

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

  2. Annabi, B

    • Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes February 1993 42:363-366; doi:10.2337/diabetes.42.2.363

  3. Aoki, S

    • Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes February 1993 42:345-350; doi:10.2337/diabetes.42.2.345

  4. Auinger, M

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

B

  1. Bennet, W M

    • Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes February 1993 42:330-335; doi:10.2337/diabetes.42.2.330

  2. Bergman, R N

    • Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes February 1993 42:250-256; doi:10.2337/diabetes.42.2.250
    • Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes February 1993 42:296-306; doi:10.2337/diabetes.42.2.296
    • Effects of epinephrine on insulin secretion and action in humans. Interaction with aging. Diabetes February 1993 42:307-315; doi:10.2337/diabetes.42.2.307

  3. Bingley, P J

    • Can we really predict IDDM? Diabetes February 1993 42:213-220; doi:10.2337/diabetes.42.2.213

  4. Blackmore, L M

    • Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes February 1993 42:341-344; doi:10.2337/diabetes.42.2.341

  5. Blackwell, C C

    • Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus. Diabetes February 1993 42:336-340; doi:10.2337/diabetes.42.2.336

  6. Bloom, S R

    • Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes February 1993 42:330-335; doi:10.2337/diabetes.42.2.330

  7. Boland, O M

    • Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus. Diabetes February 1993 42:336-340; doi:10.2337/diabetes.42.2.336

  8. Bonifacio, E

    • Can we really predict IDDM? Diabetes February 1993 42:213-220; doi:10.2337/diabetes.42.2.213

  9. Bourey, R E

    • Insulin resistance in aging is related to abdominal obesity. Diabetes February 1993 42:273-281; doi:10.2337/diabetes.42.2.273

  10. Bradley, D C

    • Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes February 1993 42:296-306; doi:10.2337/diabetes.42.2.296

  11. Byfield, P G

    • Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes February 1993 42:330-335; doi:10.2337/diabetes.42.2.330

C

  1. Chang, K

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  2. Chase, H P

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  3. Cherrington, A D

    • The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes February 1993 42:263-272; doi:10.2337/diabetes.42.2.263

  4. Clarke, B F

    • Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus. Diabetes February 1993 42:336-340; doi:10.2337/diabetes.42.2.336

  5. Clarke, W

    • Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes February 1993 42:239-243; doi:10.2337/diabetes.42.2.239

  6. Corbett, J A

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  7. Cox, D J

    • Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes February 1993 42:239-243; doi:10.2337/diabetes.42.2.239

  8. Crawford, J R

    • Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes February 1993 42:341-344; doi:10.2337/diabetes.42.2.341

  9. Cruickshanks, K J

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  10. Currie, M G

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

D

  1. Davis, S N

    • The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes February 1993 42:263-272; doi:10.2337/diabetes.42.2.263

  2. Deary, I J

    • Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes February 1993 42:341-344; doi:10.2337/diabetes.42.2.341

  3. Dimitrakoudis, D

    • Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes February 1993 42:363-366; doi:10.2337/diabetes.42.2.363

E

  1. Egawa, H

    • Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. Diabetes February 1993 42:233-238; doi:10.2337/diabetes.42.2.233

  2. Ewing, D J

    • Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus. Diabetes February 1993 42:336-340; doi:10.2337/diabetes.42.2.336

F

  1. Felipo, V

    • Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes February 1993 42:257-262; doi:10.2337/diabetes.42.2.257

  2. Finegood, D T

    • A new model for the study of mild diabetes during pregnancy. Syngeneic islet-transplanted STZ-induced diabetic rats. Diabetes February 1993 42:316-323; doi:10.2337/diabetes.42.2.316

  3. Formanek, D

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

  4. Frank, H J

    • Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes February 1993 42:351-358; doi:10.2337/diabetes.42.2.351

  5. Frier, B M

    • Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes February 1993 42:341-344; doi:10.2337/diabetes.42.2.341

G

  1. Gale, E A

    • Can we really predict IDDM? Diabetes February 1993 42:213-220; doi:10.2337/diabetes.42.2.213

  2. Gay, E C

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  3. Ghatei, M A

    • Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes February 1993 42:330-335; doi:10.2337/diabetes.42.2.330

  4. Goldstein, R E

    • The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes February 1993 42:263-272; doi:10.2337/diabetes.42.2.263

  5. Gonder-Frederick, L

    • Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes February 1993 42:239-243; doi:10.2337/diabetes.42.2.239

  6. Grisolía, S

    • Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes February 1993 42:257-262; doi:10.2337/diabetes.42.2.257

  7. Groop, L C

    • Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes February 1993 42:359-362; doi:10.2337/diabetes.42.2.359

H

  1. Halter, J B

    • Effects of epinephrine on insulin secretion and action in humans. Interaction with aging. Diabetes February 1993 42:307-315; doi:10.2337/diabetes.42.2.307

  2. Hamman, R F

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  3. Hasan, K S

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  4. Hepburn, D A

    • Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes February 1993 42:341-344; doi:10.2337/diabetes.42.2.341

  5. Herman, W H

    • Effects of epinephrine on insulin secretion and action in humans. Interaction with aging. Diabetes February 1993 42:307-315; doi:10.2337/diabetes.42.2.307

  6. Hermenegildo, C

    • Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes February 1993 42:257-262; doi:10.2337/diabetes.42.2.257

  7. Holloszy, J O

    • Insulin resistance in aging is related to abdominal obesity. Diabetes February 1993 42:273-281; doi:10.2337/diabetes.42.2.273

  8. Hu, R M

    • Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes February 1993 42:351-358; doi:10.2337/diabetes.42.2.351

I

  1. Ichikawa, T

    • Effect of STZ administration on islet isograft and allograft survival in NOD mice. Diabetes February 1993 42:324-329; doi:10.2337/diabetes.42.2.324

  2. Irsigler, K

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

  3. Itoh, T

    • Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes February 1993 42:345-350; doi:10.2337/diabetes.42.2.345

J

  1. Jacobs, J

    • The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes February 1993 42:263-272; doi:10.2337/diabetes.42.2.263

  2. Jobim, L F

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

K

  1. Kahn, S E

    • Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes February 1993 42:250-256; doi:10.2337/diabetes.42.2.250

  2. King, D S

    • Insulin resistance in aging is related to abdominal obesity. Diabetes February 1993 42:273-281; doi:10.2337/diabetes.42.2.273

  3. Kirwan, J P

    • Insulin resistance in aging is related to abdominal obesity. Diabetes February 1993 42:273-281; doi:10.2337/diabetes.42.2.273

  4. Klingensmith, G

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  5. Klip, A

    • Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes February 1993 42:363-366; doi:10.2337/diabetes.42.2.363

  6. Knowles, W

    • Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes February 1993 42:359-362; doi:10.2337/diabetes.42.2.359

  7. Kohrt, W M

    • Insulin resistance in aging is related to abdominal obesity. Diabetes February 1993 42:273-281; doi:10.2337/diabetes.42.2.273

  8. Komiyama, Y

    • Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. Diabetes February 1993 42:233-238; doi:10.2337/diabetes.42.2.233

  9. Kostraba, J N

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  10. Kuroda, Y

    • Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes February 1993 42:345-350; doi:10.2337/diabetes.42.2.345

  11. Kuwajima, S

    • Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes February 1993 42:345-350; doi:10.2337/diabetes.42.2.345

L

  1. Lahrmann, H

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

  2. Langan, S J

    • Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes February 1993 42:341-344; doi:10.2337/diabetes.42.2.341

  3. Lavoie, L

    • Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes February 1993 42:363-366; doi:10.2337/diabetes.42.2.363

  4. Lawler-Heavner, J

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  5. Levin, E R

    • Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes February 1993 42:351-358; doi:10.2337/diabetes.42.2.351

M

  1. Mackay, I R

    • Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes February 1993 42:359-362; doi:10.2337/diabetes.42.2.359

  2. Maki, T

    • Effect of STZ administration on islet isograft and allograft survival in NOD mice. Diabetes February 1993 42:324-329; doi:10.2337/diabetes.42.2.324

  3. Marette, A

    • Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes February 1993 42:363-366; doi:10.2337/diabetes.42.2.363

  4. McDaniel, M L

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  5. Merkle, M

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

  6. Miñana, M D

    • Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes February 1993 42:257-262; doi:10.2337/diabetes.42.2.257

  7. Misko, T P

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  8. Mitsuhashi, T

    • Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes February 1993 42:345-350; doi:10.2337/diabetes.42.2.345

  9. Moore, W M

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  10. Morganroth, G S

    • Effects of epinephrine on insulin secretion and action in humans. Interaction with aging. Diabetes February 1993 42:307-315; doi:10.2337/diabetes.42.2.307

  11. Morrow, L A

    • Effects of epinephrine on insulin secretion and action in humans. Interaction with aging. Diabetes February 1993 42:307-315; doi:10.2337/diabetes.42.2.307

  12. Murakami, T

    • Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. Diabetes February 1993 42:233-238; doi:10.2337/diabetes.42.2.233

  13. Murata, K

    • Elevation of factor XIa-alpha 1-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. Diabetes February 1993 42:233-238; doi:10.2337/diabetes.42.2.233

N

  1. Nakagawa, S

    • Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes February 1993 42:345-350; doi:10.2337/diabetes.42.2.345

  2. Nakayama, H

    • Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat. Diabetes February 1993 42:345-350; doi:10.2337/diabetes.42.2.345

P

  1. Pedram, A

    • Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes February 1993 42:351-358; doi:10.2337/diabetes.42.2.351

  2. Petrash, J M

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  3. Philippe, J

    • Somatostatin inhibits insulin-gene expression through a posttranscriptional mechanism in a hamster islet cell line. Diabetes February 1993 42:244-249; doi:10.2337/diabetes.42.2.244

  4. Poulin, R A

    • Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes February 1993 42:296-306; doi:10.2337/diabetes.42.2.296

  5. Price, L

    • The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes February 1993 42:263-272; doi:10.2337/diabetes.42.2.263

R

  1. Rewers, M J

    • Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes February 1993 42:288-295; doi:10.2337/diabetes.42.2.288

  2. Romero, F J

    • Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes February 1993 42:257-262; doi:10.2337/diabetes.42.2.257

  3. Rowley, M J

    • Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes February 1993 42:359-362; doi:10.2337/diabetes.42.2.359

  4. Ryan, E A

    • A new model for the study of mild diabetes during pregnancy. Syngeneic islet-transplanted STZ-induced diabetic rats. Diabetes February 1993 42:316-323; doi:10.2337/diabetes.42.2.316

S

  1. Smith, D M

    • Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes February 1993 42:330-335; doi:10.2337/diabetes.42.2.330

  2. Smith, S R

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  3. Staten, M A

    • Insulin resistance in aging is related to abdominal obesity. Diabetes February 1993 42:273-281; doi:10.2337/diabetes.42.2.273

  4. Steil, G M

    • Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes February 1993 42:250-256; doi:10.2337/diabetes.42.2.250

T

  1. Takayama, Y

    • Effect of STZ administration on islet isograft and allograft survival in NOD mice. Diabetes February 1993 42:324-329; doi:10.2337/diabetes.42.2.324

  2. Tang, J

    • A new model for the study of mild diabetes during pregnancy. Syngeneic islet-transplanted STZ-induced diabetic rats. Diabetes February 1993 42:316-323; doi:10.2337/diabetes.42.2.316

  3. Tilton, R G

    • Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes February 1993 42:221-232; doi:10.2337/diabetes.42.2.221

  4. Tobin, B W

    • A new model for the study of mild diabetes during pregnancy. Syngeneic islet-transplanted STZ-induced diabetic rats. Diabetes February 1993 42:316-323; doi:10.2337/diabetes.42.2.316

  5. Tuomi, T

    • Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes February 1993 42:359-362; doi:10.2337/diabetes.42.2.359

V

  1. van de Werve, G

    • Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes February 1993 42:363-366; doi:10.2337/diabetes.42.2.363

  2. Volund, A

    • Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes February 1993 42:250-256; doi:10.2337/diabetes.42.2.250

  3. Vranic, M

    • Opposite effects of hyperglycemia and insulin deficiency on liver glycogen synthase phosphatase activity in the diabetic rat. Diabetes February 1993 42:363-366; doi:10.2337/diabetes.42.2.363

W

  1. Wang, Z L

    • Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes February 1993 42:330-335; doi:10.2337/diabetes.42.2.330

  2. Wanke, T

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

  3. Wolfe, R

    • The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes February 1993 42:263-272; doi:10.2337/diabetes.42.2.263

Z

  1. Zimmet, P Z

    • Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes February 1993 42:359-362; doi:10.2337/diabetes.42.2.359

  2. Zwick, H

    • No effect of naloxone on ventilatory response to progressive hypercapnia in IDDM patients. Diabetes February 1993 42:282-287; doi:10.2337/diabetes.42.2.282

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement